According to Millennium Research Group (MRG), the global authority on medical technology market intelligence, high market opportunity in the European embolization coil market has led to several major acquisitions in 2010. The European market alone was valued at approximately $100 million in 2009, making successful niche competitors in this market attractive acquisition targets.
Although novel devices in the embolization coil market have shown promise, adoption of these devices is highly dependent on clinical trial results and regulatory approvals. In order to succeed, companies need to collect favorable clinical data supporting the efficacy of their devices. Gathering these results can be difficult for smaller companies that do not have the funding or resources to conduct large-scale clinical trials. For these competitors, it is often beneficial to develop relationships with larger companies in the form of partnerships or acquisitions. It is also beneficial for the acquiring company, which can leverage vast sales and marketing resources to sell innovative new products.